Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.11 | 0.7 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.062 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |